Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
187.15
22.3 (13.53%)
BSENSE

Apr 01

BSE+NSE Vol: 63.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 601817,
    "name": "Indoco Remedies",
    "stock_name": "Indoco Remedies",
    "full_name": "Indoco Remedies Ltd",
    "name_url": "stocks-analysis/indoco-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "187.15",
    "chg": 22.3,
    "chgp": "13.53%",
    "dir": 1,
    "prev_price": "164.85",
    "mcapval": "1,619.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532612,
    "symbol": "INDOCO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE873D01024",
    "curr_date": "Apr 01",
    "curr_time": "",
    "bse_nse_vol": "63.34 k",
    "exc_status": "Active",
    "traded_date": "Apr 01, 2026",
    "traded_date_str": "2026 04 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indoco-remedies-601817-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indoco Remedies Ltd Surges 7.83% to Day's High of Rs 178.7 — Outperforms Sector by 6.23 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-hits-intraday-high-with-783-surge-on-1-april-2026-3928727",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndocoRemediesL_priceRelatedfactors_3928727.png",
        "date": "2026-04-01 10:21:08",
        "description": "The Sensex advanced 2.76% on 1 Apr 2026, yet Indoco Remedies Ltd outpaced the broader market with a 7.83% gain, reaching an intraday high of Rs 178.7. This 6.23-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.07% rise signals a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Five Consecutive Losses Push Indoco Remedies Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-falls-to-52-week-low-amid-continued-downtrend-3924415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3924415.png",
        "date": "2026-03-30 11:04:49",
        "description": "For the fifth consecutive session, Indoco Remedies Ltd closed lower, slipping to a fresh 52-week low of Rs 166.75 on 30 Mar 2026. This marks a near 10% decline over the past three days, underscoring persistent selling pressure despite a broader market that has shown some resilience."
      },
      {
        "title": "Markets Rally, But Indoco Remedies Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-hits-52-week-low-amid-continued-downtrend-3919280",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3919280.png",
        "date": "2026-03-27 11:20:35",
        "description": "While the broader market shows signs of recovery, Indoco Remedies Ltd has continued its downward trajectory, hitting a fresh 52-week low of Rs 173.35 on 27 Mar 2026. This decline comes amid a sharp underperformance relative to its sector and benchmark indices, raising questions about the underlying factors weighing on the stock."
      },
      {
        "title": "Markets Rally, But Indoco Remedies Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-falls-to-52-week-low-amidst-continued-underperformance-3910352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3910352.png",
        "date": "2026-03-24 11:44:31",
        "description": "While the broader market shows signs of recovery, Indoco Remedies Ltd has slipped to a fresh 52-week low of Rs 180.85 on 24 Mar 2026, extending its recent downward trajectory amid persistent financial headwinds and sector underperformance."
      },
      {
        "title": "Markets Rally, But Indoco Remedies Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-hits-52-week-low-at-rs187-amidst-continued-downtrend-3907752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3907752.png",
        "date": "2026-03-23 12:09:22",
        "description": ""
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3905994",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_mojoScore_3905994.png",
        "date": "2026-03-23 10:10:16",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Indoco Remedies Ltd Stock Falls to 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-falls-to-52-week-low-amidst-continued-underperformance-3897002",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3897002.png",
        "date": "2026-03-17 16:01:41",
        "description": "Indoco Remedies Ltd has recently touched a 52-week low, closing just 1.65% above its lowest price of Rs 188, marking a significant decline in the stock’s valuation over the past year. This development comes amid a backdrop of persistent financial headwinds and subdued market performance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Indoco Remedies Ltd Stock Falls to 52-Week Low of Rs.188.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indoco-remedies-ltd-stock-falls-to-52-week-low-of-rs1889-3894232",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_priceRelatedfactors_3894232.png",
        "date": "2026-03-16 14:06:24",
        "description": "Indoco Remedies Ltd has reached a new 52-week low, with its stock price dropping to Rs.188.9 today, marking a significant decline amid broader market pressures and company-specific financial concerns."
      },
      {
        "title": "Indoco Remedies Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indoco-remedies-ltd-is-rated-strong-sell-3886725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndocoRemediesL_mojoScore_3886725.png",
        "date": "2026-03-12 10:10:18",
        "description": "Indoco Remedies Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Dec 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 March 2026, providing investors with the latest insights into its performance and outlook."
      }
    ],
    "total": 546,
    "sid": "601817",
    "stock_news_url": "https://www.marketsmojo.com/news/indoco-remedies-601817"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Intimation regarding Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-Mar-2026",
      "details": "Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company will be participating in the 11th Annual Valorem Conference-Resilient Corporates Relentless India organised by Valorem Advisors .",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "24-Feb-2026",
      "details": "Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution 10mg/mL",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has declared <strong>10%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indoco Remedies Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 17 May 12",
          "dt": "2012-05-17",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Closure of Trading Window

30-Mar-2026 | Source : BSE

Intimation regarding Closure of Trading Window

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

13-Mar-2026 | Source : BSE

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the senior management of the Company will be participating in the 11th Annual Valorem Conference-Resilient Corporates Relentless India organised by Valorem Advisors .

Announcement under Regulation 30 (LODR)-Press Release / Media Release

24-Feb-2026 | Source : BSE

Indoco Remedies receives final ANDA approval from USFDA for Brivaracetam Oral Solution 10mg/mL

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Indoco Remedies Ltd has declared 10% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

Indoco Remedies Ltd has announced 2:10 stock split, ex-date: 17 May 12

stock-summary
BONUS

Indoco Remedies Ltd has announced 1:2 bonus issue, ex-date: 17 May 12

stock-summary
RIGHTS

No Rights history available